What is Starch, Alpha-amylase Modified?
Starch, Alpha-amylase Modified (CAS Number 977162-55-2) is a starch derivative produced through enzymatic modification using alpha-amylase, an enzyme that hydrolyzes alpha-1,4-glycosidic bonds in starch molecules. This process alters the starch's molecular structure, reducing its chain length and modifying its functional properties. The resulting ingredient differs from native starch in its viscosity, gelling capacity, and solubility characteristics.
Alpha-amylase is a naturally occurring enzyme found in saliva, pancreatic secretions, and various microorganisms. The modification process is a common industrial practice for creating starches with enhanced or altered functional properties suitable for specific food applications.
Common Uses
While the specific applications of this particular modified starch variant are not clearly documented in public FDA databases, enzymatically modified starches generally serve several functions in food manufacturing:
- Thickening agents in sauces, gravies, and soups
- Stabilizers in dairy products and puddings
- Texture modifiers in baked goods and processed foods
- Binding agents in meat products
- Film-forming agents in certain applications
The enzymatic modification typically produces starches with reduced viscosity compared to native starches, making them useful in applications requiring specific flow properties or reduced cooking times.
Safety Assessment
Starch, Alpha-amylase Modified has generated zero reported adverse events in FDA databases and has not been associated with any food recalls. This absence of adverse event reports suggests no identified safety concerns have emerged from its use in food products.
The safety profile of enzymatically modified starches is generally supported by their long history of use. Alpha-amylase itself is recognized as a safe enzyme used in numerous food and beverage applications, including bread making and beverage production. The enzyme is typically inactivated during processing or is present in negligible quantities in the final product.
Modified starches are poorly absorbed in the human digestive system and primarily pass through the gastrointestinal tract without significant metabolism, similar to dietary fiber. This characteristic contributes to their generally recognized safety status in the food industry.
As with all food additives, consumption occurs in limited quantities as part of formulated food products rather than as direct consumption, further reducing potential exposure.
Regulatory Status
Starch, Alpha-amylase Modified has not received FDA GRAS (Generally Recognized as Safe) status, according to available public databases. This designation does not necessarily indicate safety concerns; rather, it may reflect limited documentation of its specific uses or insufficient formal petition submissions for GRAS approval.
The lack of GRAS status means this ingredient may be subject to FDA food additive regulations requiring pre-market approval, though specific regulatory requirements depend on its intended use and the food categories in which it appears.
Without documented adverse events or recalls, and given the safety history of enzymatically modified starches broadly, the regulatory pathway for this ingredient would depend on demonstrating its safety through appropriate toxicological studies if formal approval were sought.
Key Studies
Specific published studies focusing exclusively on Starch, Alpha-amylase Modified with CAS Number 977162-55-2 are not readily available in peer-reviewed literature databases. However, extensive research supports the safety of enzymatically modified starches and alpha-amylase as food ingredients:
- General enzymatic starch modification has been studied for decades with established safety profiles
- Alpha-amylase is listed on the FDA's enzyme preparation database as safe for food use
- Modified starch ingredients have undergone safety evaluations by regulatory bodies including EFSA (European Food Safety Authority)
The absence of specific toxicological studies for this particular starch variant, combined with zero adverse events and recalls, suggests either limited commercial use or a product that has not generated safety concerns warranting formal investigation.